![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/18/2900267/0/en/PolyPid-Hosts-KOL-Call-to-Discuss-Significant-Unmet-Medical-Need-in-Surgical-Site-Infections-Prevention-and-Provides-Update-on-its-Ongoing-SHIELD-II-Phase-3-Trial.html
https://www.globenewswire.com/news-release/2024/06/10/2895869/0/en/PolyPid-to-Host-Virtual-KOL-Event-on-June-17-2024-and-Provide-an-Update-on-the-Company-s-Ongoing-D-PLEX-Phase-3-Trial.html
https://www.globenewswire.com/news-release/2024/05/08/2877672/0/en/PolyPid-Provides-Corporate-Update-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/01/2873084/0/en/PolyPid-to-Participate-in-Citizens-JMP-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/04/30/2872040/0/en/PolyPid-Announces-Enrollment-of-200th-Patient-in-Ongoing-SHIELD-II-Phase-3-Trial-Evaluating-D-PLEX-for-the-Prevention-of-Abdominal-Colorectal-Surgical-Site-Infections.html
https://www.globenewswire.com/news-release/2024/04/24/2868439/0/en/PolyPid-to-Report-First-Quarter-2024-Financial-Results-and-Operational-Highlights-on-May-8-2024.html
https://www.globenewswire.com//news-release/2024/02/28/2836793/0/en/PolyPid-to-Participate-in-Barclays-26th-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/12/2827386/0/en/PolyPid-Announces-Enrollment-of-the-100th-Patient-in-the-Ongoing-SHIELD-II-Phase-3-Trial.html
https://www.globenewswire.com//news-release/2024/01/04/2804359/0/en/PolyPid-Announces-Private-Placement-for-16-Million-in-Gross-Proceeds.html
https://www.globenewswire.com//news-release/2023/11/08/2776036/0/en/PolyPid-Provides-Corporate-Update-and-Reports-Third-Quarter-2023-Financial-Results.html